Does ERYTHROPOIETIN Cause Neoplasm progression? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Neoplasm progression have been filed in association with ERYTHROPOIETIN. This represents 0.5% of all adverse event reports for ERYTHROPOIETIN.
37
Reports of Neoplasm progression with ERYTHROPOIETIN
0.5%
of all ERYTHROPOIETIN reports
2
Deaths
35
Hospitalizations
How Dangerous Is Neoplasm progression From ERYTHROPOIETIN?
Of the 37 reports, 2 (5.4%) resulted in death, 35 (94.6%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROPOIETIN. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROPOIETIN Cause?
Product storage error (1,286)
Death (871)
Circumstance or information capable of leading to medication error (592)
Off label use (590)
Haemoglobin decreased (443)
Drug ineffective (370)
Anaemia (367)
Intercepted product administration error (301)
Incorrect product storage (268)
Fatigue (266)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which ERYTHROPOIETIN Alternatives Have Lower Neoplasm progression Risk?
ERYTHROPOIETIN vs ESCHERICHIA COLI
ERYTHROPOIETIN vs ESCITALOPRAM
ERYTHROPOIETIN vs ESCITALOPRAM OXALATE
ERYTHROPOIETIN vs ESKETAMINE
ERYTHROPOIETIN vs ESLICARBAZEPINE